Effect of wide chest aerosol on TID ratio of myocardial perfusionimaging and cardiac reserve function in patients with coronary microvascular dysfunction

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046560

Enrollment

Unknown

Registered

2021-05-21

Start date

2021-01-01

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary microvascular dysfunction

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20 to 75 years; 2. With symptoms of chest pain and had taken antiplatelet and statins before admission; 3. Coronary artery stenosis =1.2, or transmural ischemia positive, or cold pressor test positive.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Nitrate esters are prohibited and used cautiously; 3.Cognitive impairment, unable to cooperate; 4.Severe damage of liver and kidney function and mental abnormality; 5.Severe cardiopulmonary insufficiency and malignant arrhythmia; 6.Those who participated in other clinical trials at the same time.

Design outcomes

Primary

Measure	Time frame
transient ischemic dilation, TID;total perfusion defect, TPD;cold pressor test, CPT;	—

Secondary

Measure	Time frame
left ventricular ejection fraction, LVEF;peak filling rate, PFR;	—

Countries

China

Contacts

Public ContactLi Zhigang

Xuzhou Central Hospital

liguoquantcm@163.com+86 15351687309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026